TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

43.30$ -2.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ALKS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
28.4% 22.1% 17.7% 17.1% 16.1% 15.4% 17.2% 16.8% 19.6% 15.2% 15.8% 13.3%
71.6% 77.9% 82.3% 82.9% 83.9% 84.6% 82.8% 83.2% 80.4% 84.8% 84.2% 86.7%
44.0% 54.8% 51.9% 45.7% 38.9% 43.8% 38.0% 24.8% 24.5% 16.3% 15.7% 22.0%
32.3% 49.6% 50.2% 46.7% 48.1% 48.5% 49.4% 43.5% 17.9% 12.0% 12.8% 42.3%
85.7% 113.6% 110.3% 99.2% 92.9% 99.6% 93.7% 74.9% 80.9% 59.9% 57.2% 69.5%
-14.1% -35.7% -28.0% -16.4% -9.1% -15.0% -10.8% 8.3% -0.5% 24.9% 27.0% 17.2%
2.2% 2.1% 2.0% 1.3% 1.4% 1.2% 0.8% 1.0% 1.2% 1.4% 1.4% 0.8%
-2.3% -35.7% -28.7% -15.9% -11.6% -16.8% -9.3% 7.5% -2.8% 25.3% 28.5% 19.7%
2.6% 0.5% -0.8% 1.6% 1.1% 0.0% 1.4% 1.0% 0.2% -5.9% 4.6% 3.4%
-4.9% -36.2% -28.0% -17.5% -12.7% -16.8% -10.7% -4.1% -14.2% 21.4% 23.6% 16.4%
15.8% -19.9% -14.1% -3.6% -0.7% -8.8% -0.6% 15.1% 5.4% 31.2% 31.8% 22.4%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?